Cancer is one of those illnesses that has been around for many years and it has affected the lives of many people either directly or indirectly. There have been many advancements throughout the years, but none were able to make a huge impact until now. Have you ever heard of a guy named Clay Siegall? Seattle Genetics is one of the leading biotech organizations that specialize in the development and commercialization of cancer breakthrough therapies. Clay Siegall is the current CEO and President of this exclusive organization and this duo is revolutionizing cancer research through innovation.
Clay Siegall is a well-respected individual in this industry and he one of the most impressive resume’s to back it up. This guy has a Ph.D in Genetics from George Washington University as well as a (BS) in Zoology from the University of Maryland. He’s thought of as a “man of man acts” also thanks to having such a broad educational background in a variety of subjects. Siegal’s huge heart has allowed him to help and save many lives throughout his professional career as he’s worked with many high profile organizations such as The National Cancer Institute, Bristol Myers Squibb, and The National Institute of Health. Seattle Genetics has grown into a powerhouse that hosts over 800 employees. Antibody Drug Conjugates are some of the best cancer fighting medications and this organization produces the best. Dr. Siegal has entered the advanced medications into multiple strategic deals with GlaxoSmithKline, Pfizer, and Genentech. Having these deals allow the powerful medications to be used in other countries. As of today, Seattle Genetics’ (ADCs) have brought in over $325 Million in sales.
Thanks to the organization’s solid reputation and remarkable products, Seattle Genetics was ranked on the Forbes list as one of the fastest growing companies in the U.S. Dr. Clay Siegall’s vision is finally coming true and the number of lives he has saved is a true testament to his success.